tiprankstipranks
Trending News
More News >
Dianthus Therapeutics, Inc. (DNTH)
:DNTH
US Market

Dianthus Therapeutics (DNTH) Ratios

Compare
314 Followers

Dianthus Therapeutics Ratios

DNTH's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, DNTH's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
15.22 18.42 9.97 1.75 13.26
Quick Ratio
15.22 18.42 9.87 1.70 13.26
Cash Ratio
1.24 13.74 1.87 1.43 5.09
Solvency Ratio
-3.93 -4.10 -0.22 -0.42 -4.12
Operating Cash Flow Ratio
-4.24 -3.83 -3.53 -1.85 -5.60
Short-Term Operating Cash Flow Coverage
-244.31 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 259.37M$ 166.92M$ -45.45M$ -17.31M$ 133.81M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 0.00 0.00
Debt-to-Equity Ratio
<0.01 <0.01 -0.02 0.00 0.00
Debt-to-Capital Ratio
<0.01 <0.01 -0.02 0.00 0.00
Long-Term Debt-to-Capital Ratio
<0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.06 1.06 -1.87 -0.55 1.12
Debt Service Coverage Ratio
-318.32 0.00 0.00 -3.12 -21.37
Interest Coverage Ratio
0.00 0.00 0.00 -3.68 -20.90
Debt to Market Cap
<0.01 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.04 0.11 0.21 1.04 1.37
Net Debt to EBITDA
0.21 2.73 0.49 0.58 0.80
Profitability Margins
Gross Profit Margin
93.39%87.44%97.71%-36.86%0.00%
EBIT Margin
-1633.74%-1704.67%-462.91%-886.59%0.00%
EBITDA Margin
-1633.74%-1704.67%-460.62%-886.59%0.00%
Operating Profit Margin
-1633.74%-1704.67%-462.91%-886.59%0.00%
Pretax Profit Margin
-1362.77%-1541.22%-443.76%-888.14%0.00%
Net Profit Margin
-1362.77%-1541.22%-443.76%-888.14%0.00%
Continuous Operations Profit Margin
-1362.77%-1541.22%-443.76%-888.14%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
83.41%90.41%95.86%100.18%95.21%
Return on Assets (ROA)
-22.72%-24.28%-34.26%-138.70%-46.37%
Return on Equity (ROE)
-24.11%-25.79%64.18%76.00%-52.07%
Return on Capital Employed (ROCE)
-28.65%-28.38%-39.67%-319.25%-52.40%
Return on Invested Capital (ROIC)
-28.62%-28.31%-37.71%-270.61%-57.67%
Return on Tangible Assets
-22.72%-24.28%-34.26%-138.70%-46.37%
Earnings Yield
-11.38%-81.27%-120.24%-5.39%-21.76%
Efficiency Ratios
Receivables Turnover
7.73 5.91 1.14 1.00 0.00
Payables Turnover
0.00 0.14 0.13 1.49 0.53
Inventory Turnover
0.00 0.00 0.17 7.65 0.00
Fixed Asset Turnover
3.57 3.53 6.71 44.73 0.00
Asset Turnover
0.02 0.02 0.08 0.16 0.00
Working Capital Turnover Ratio
0.03 0.02 0.16 0.02 0.00
Cash Conversion Cycle
47.24 -2.62K -461.45 167.14 -693.83
Days of Sales Outstanding
47.24 61.74 320.69 365.00 0.00
Days of Inventory Outstanding
0.00 0.00 2.12K 47.70 0.00
Days of Payables Outstanding
0.00 2.68K 2.90K 245.56 693.83
Operating Cycle
47.24 61.74 2.44K 412.70 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-2.28 -7.15 -7.76 -2.88 -23.32
Free Cash Flow Per Share
-2.29 -7.17 -7.79 -2.89 -23.47
CapEx Per Share
<0.01 0.02 0.04 <0.01 0.15
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-744.57 -335.10 -209.14 -300.12 -160.06
Capital Expenditure Coverage Ratio
-744.57 -335.10 -209.14 -300.12 -160.06
Operating Cash Flow Coverage Ratio
-52.43 -63.01 -36.89 0.00 0.00
Operating Cash Flow to Sales Ratio
-12.54 -13.04 -4.53 -6.71 0.00
Free Cash Flow Yield
-10.49%-68.98%-123.34%-4.08%-18.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.78 -1.23 -0.83 -18.57 -4.60
Price-to-Sales (P/S) Ratio
119.70 18.97 3.69 164.92 0.00
Price-to-Book (P/B) Ratio
2.12 0.32 -0.53 -14.11 2.39
Price-to-Free Cash Flow (P/FCF) Ratio
-9.53 -1.45 -0.81 -24.50 -5.34
Price-to-Operating Cash Flow Ratio
-9.55 -1.45 -0.81 -24.58 -5.38
Price-to-Earnings Growth (PEG) Ratio
0.12 -0.11 >-0.01 0.22 0.26
Price-to-Fair Value
2.12 0.32 -0.53 -14.11 2.39
Enterprise Value Multiple
-7.12 1.62 -0.31 -18.02 -3.92
Enterprise Value
725.06M -78.14M 9.11M 235.79M 286.18M
EV to EBITDA
-7.12 1.62 -0.31 -18.02 -3.92
EV to Sales
116.29 -27.65 1.42 159.75 0.00
EV to Free Cash Flow
-9.26 2.11 -0.31 -23.73 -4.44
EV to Operating Cash Flow
-9.27 2.12 -0.31 -23.81 -4.47
Tangible Book Value Per Share
10.30 32.77 -11.84 -5.02 52.42
Shareholders’ Equity Per Share
10.30 32.77 -11.84 -5.02 52.42
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.04 0.15 -0.10
Revenue Per Share
0.18 0.55 1.71 0.43 0.00
Net Income Per Share
-2.48 -8.45 -7.60 -3.82 -27.30
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.83 0.90 0.96 1.00 1.00
Research & Development to Revenue
13.33 11.62 4.58 8.54 0.00
SG&A to Revenue
4.01 6.43 1.05 1.33 0.00
Stock-Based Compensation to Revenue
2.07 1.03 0.24 0.04 0.00
Income Quality
0.92 0.85 1.02 0.76 0.85
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis